Schultes Birgit C

EDGAR CIK 0002051419

Intellia Therapeutics, Inc. - NTLA

  1. Manufacturing
  2. Chemicals
  3. In Vitro & In Vivo Diagnostic Substances
Officer
EVP, Chief Scientific Officer
Direct Buys
0
$0
0 Shares
Direct Sells
2
($78,897)
-8,539 Shares
Indirect Buys
0
$0
0 Shares
Indirect Sells
0
$0
0 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
01/05/2026
01/07/2026
Sell
-8,508 @ $9.21
 ($78,359) 98,533 (-7.95%) Direct
10/01/2025
10/03/2025
Sell
-31 @ $17.38
 ($539) 105,184 (-0.03%) Direct